$Hims & Hers Health(HIMS.US) is this positive news

LongPort - Reuters
Reuters

EXCLUSIVE-Hims and Hers Health launches copy of Wegovy pill at $49

Hims and Hers Health has launched a copy of Novo Nordisk's Wegovy pill at an introductory price of $49 per month, significantly lower than the brand name's price. The compounded version contains the same active ingredient, semaglutide. Hims offers various subscription plans, with a 5-month plan costing $99 per month after the initial payment. The launch comes amid pricing pressures faced by Novo, which has seen a drop in its shares due to competition and market shifts. Hims previously faced FDA warnings regarding its marketing of compounded semaglutide.

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.